AR016629A1 - Una solucion que comprende un azaesteroide farmaceuticamente activo y un ester de acido graso de glicerol o propilen glicol, composiciones farmaceuticasque comprenden la solucion y capsulas de gelatina rellenas con la composicion farmaceutica. - Google Patents
Una solucion que comprende un azaesteroide farmaceuticamente activo y un ester de acido graso de glicerol o propilen glicol, composiciones farmaceuticasque comprenden la solucion y capsulas de gelatina rellenas con la composicion farmaceutica.Info
- Publication number
- AR016629A1 AR016629A1 ARP980104050A ARP980104050A AR016629A1 AR 016629 A1 AR016629 A1 AR 016629A1 AR P980104050 A ARP980104050 A AR P980104050A AR P980104050 A ARP980104050 A AR P980104050A AR 016629 A1 AR016629 A1 AR 016629A1
- Authority
- AR
- Argentina
- Prior art keywords
- solution
- fatty acid
- acid ester
- pharmaceutically active
- propiles
- Prior art date
Links
- 239000002775 capsule Substances 0.000 title abstract 3
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 3
- -1 GLICEROL FATTY ACID Chemical class 0.000 title abstract 2
- 235000014113 dietary fatty acids Nutrition 0.000 title abstract 2
- 229930195729 fatty acid Natural products 0.000 title abstract 2
- 239000000194 fatty acid Substances 0.000 title abstract 2
- 229920000159 gelatin Polymers 0.000 title abstract 2
- 235000019322 gelatine Nutrition 0.000 title abstract 2
- 239000001828 Gelatine Substances 0.000 title 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 abstract 3
- 108010010803 Gelatin Proteins 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 150000001735 carboxylic acids Chemical class 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000008273 gelatin Substances 0.000 abstract 1
- 235000011852 gelatine desserts Nutrition 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9717428.8A GB9717428D0 (en) | 1997-08-19 | 1997-08-19 | Pharmaceutical composition |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR016629A1 true AR016629A1 (es) | 2001-07-25 |
Family
ID=10817619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP980104050A AR016629A1 (es) | 1997-08-19 | 1998-08-14 | Una solucion que comprende un azaesteroide farmaceuticamente activo y un ester de acido graso de glicerol o propilen glicol, composiciones farmaceuticasque comprenden la solucion y capsulas de gelatina rellenas con la composicion farmaceutica. |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP1007010A2 (pt) |
| JP (1) | JP2002511101A (pt) |
| KR (1) | KR20010014080A (pt) |
| CN (1) | CN1263461A (pt) |
| AR (1) | AR016629A1 (pt) |
| AU (1) | AU9343098A (pt) |
| BR (1) | BR9810458A (pt) |
| CA (1) | CA2295016A1 (pt) |
| CO (1) | CO4960657A1 (pt) |
| GB (1) | GB9717428D0 (pt) |
| MA (1) | MA26531A1 (pt) |
| PE (1) | PE105699A1 (pt) |
| TR (1) | TR199903209T2 (pt) |
| WO (1) | WO1999008666A2 (pt) |
| ZA (1) | ZA987392B (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IS6633A (is) * | 2002-11-22 | 2004-05-23 | Omega Farma Ehf. | Samsetningar af fínasteríð töflum |
| CN102552917A (zh) | 2003-08-13 | 2012-07-11 | 比奥孔有限公司 | 用于治疗剂的微-粒子脂肪酸盐固体剂量制剂 |
| WO2005066195A1 (de) * | 2004-01-02 | 2005-07-21 | Pharmacon Forschung Und Beratung Gmbh | Verfahren zur herstellung von 1,2-ungesättigten azasteroiden |
| WO2006055659A2 (en) * | 2004-11-15 | 2006-05-26 | Smithkline Beecham Corporation | Fixed dose combination op dutasteride and tamsulosin |
| WO2010117873A2 (en) | 2009-04-06 | 2010-10-14 | Banner Pharmacaps, Inc. | Progesterone solutions for increased bioavailability |
| ES2385240B1 (es) | 2010-07-26 | 2013-09-23 | Gp-Pharm, S.A. | Cápsulas de principios activos farmacéuticos y ácidos grasos poliinsaturados para el tratamiento de enfermedades de la próstata. |
| US8900631B2 (en) | 2011-04-28 | 2014-12-02 | Health Science Funding, LLC | Dosage form to increase prasterone bioavailability |
| CN103169712B (zh) * | 2011-12-20 | 2017-10-27 | 重庆华邦制药有限公司 | 提高生物利用度的度他雄胺制剂及其制备方法 |
| WO2014002015A1 (en) | 2012-06-25 | 2014-01-03 | Ranbaxy Laboratories Limited | Pharmaceutical composition comprising dutasteride |
| ES2555485T1 (es) | 2014-05-26 | 2016-01-04 | Galenicum Health S.L. | Composiciones farmacéuticas que contienen un agente activo |
| KR101679992B1 (ko) | 2015-12-31 | 2016-11-28 | 주식회사 유유제약 | 프로필렌글리콜 모노라우레이트를 포함하는 두타스테리드의 약학적 조성물 및 이의 제조 방법 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5571817A (en) * | 1984-02-27 | 1996-11-05 | Merck & Co., Inc. | Methods of treating androgenic alopecia with finasteride [17β-N-mono-substituted-carbamoyl-4-aza-5-α-androst-1-en-ones] |
| DE3607651A1 (de) * | 1986-03-06 | 1987-09-10 | Schering Ag | Kombination von aromatasehemmer und testosteron-5(alpha)-reduktase-hemmer |
| TW369521B (en) * | 1993-09-17 | 1999-09-11 | Smithkline Beecham Corp | Androstenone derivative |
| TW408127B (en) * | 1993-09-17 | 2000-10-11 | Glaxo Inc | Androstenones |
| US5550134A (en) * | 1995-05-10 | 1996-08-27 | Eli Lilly And Company | Methods for inhibiting bone loss |
-
1997
- 1997-08-19 GB GBGB9717428.8A patent/GB9717428D0/en active Pending
-
1998
- 1998-08-12 MA MA25211A patent/MA26531A1/fr unknown
- 1998-08-14 AR ARP980104050A patent/AR016629A1/es unknown
- 1998-08-14 PE PE1998000735A patent/PE105699A1/es not_active Application Discontinuation
- 1998-08-17 BR BR9810458-6A patent/BR9810458A/pt not_active Application Discontinuation
- 1998-08-17 ZA ZA9807392A patent/ZA987392B/xx unknown
- 1998-08-17 TR TR1999/03209T patent/TR199903209T2/xx unknown
- 1998-08-17 AU AU93430/98A patent/AU9343098A/en not_active Abandoned
- 1998-08-17 CN CN98806380A patent/CN1263461A/zh active Pending
- 1998-08-17 KR KR19997012116A patent/KR20010014080A/ko not_active Withdrawn
- 1998-08-17 WO PCT/EP1998/005194 patent/WO1999008666A2/en not_active Ceased
- 1998-08-17 EP EP98946351A patent/EP1007010A2/en not_active Withdrawn
- 1998-08-17 JP JP51280899A patent/JP2002511101A/ja active Pending
- 1998-08-17 CA CA002295016A patent/CA2295016A1/en not_active Abandoned
- 1998-08-18 CO CO98047010A patent/CO4960657A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO1999008666A3 (en) | 1999-04-15 |
| CN1263461A (zh) | 2000-08-16 |
| KR20010014080A (ko) | 2001-02-26 |
| CO4960657A1 (es) | 2000-09-25 |
| AU9343098A (en) | 1999-03-08 |
| WO1999008666A2 (en) | 1999-02-25 |
| GB9717428D0 (en) | 1997-10-22 |
| PE105699A1 (es) | 1999-11-25 |
| ZA987392B (en) | 2000-02-17 |
| EP1007010A2 (en) | 2000-06-14 |
| BR9810458A (pt) | 2000-09-05 |
| TR199903209T2 (xx) | 2000-05-22 |
| MA26531A1 (fr) | 2004-12-20 |
| CA2295016A1 (en) | 1999-02-25 |
| JP2002511101A (ja) | 2002-04-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1173153T3 (da) | Orale farmaceutiske præparater, som indeholder langkædede triglycerider og lipofile overfladeaktive midler | |
| LV11884A (lv) | Ciklosporina oralas arstnieciskas formas ar augstu biopieejamibu | |
| ES2052645T3 (es) | Acidos poliinsaturados con accion vasocinetica y formulaciones farmaceuticas y cosmeticas que los contienen. | |
| AR016629A1 (es) | Una solucion que comprende un azaesteroide farmaceuticamente activo y un ester de acido graso de glicerol o propilen glicol, composiciones farmaceuticasque comprenden la solucion y capsulas de gelatina rellenas con la composicion farmaceutica. | |
| DK0904064T3 (da) | Orale farmaceutiske præparater indeholdende kønshormoner | |
| ATE15443T1 (de) | Essbare, pharmazeutische zusammensetzungen und verfahren zur herstellung. | |
| ID30205A (id) | Asam-asam lemak esensial dalam pencegahan kejadian-kejadian kardiovaskular | |
| NO940277L (no) | Triglycerider og blandinger av slike | |
| GB8305693D0 (en) | Pharmaceutical compositions | |
| IE830114L (en) | Propylene glycol diester solutions of pge-type compounds | |
| ES2134953T3 (es) | Capsulas de gelatina que contienen una solucion de acetaminofeno altamente concentrada. | |
| HRP20020206B1 (en) | Solid lipid formulations | |
| DE3171928D1 (en) | Pharmaceutical formulation and its preparation | |
| UY26303A1 (es) | Composiciones farmacéuticas para administración oral y tópica | |
| BR9712268A (pt) | Micrpesferas farmaceuticas de acido valproico para administraçao | |
| DK0657164T3 (da) | Farmaceutiske præparater indeholdende staurosporinderivater og et polyalkylenglycolglycerid | |
| SE8104657L (sv) | Injicerbara farmaceutiska kompositioner | |
| MY130474A (en) | Oral pharmaceutical compositions containing long-chain triglycerides and lipophilic surfactants |